Apollo Medical Holdings Stock Current Valuation
| 3AM Stock | EUR 28.60 1.00 3.62% |
Valuation analysis of Apollo Medical Holdings helps investors to measure Apollo Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Apollo Medical's price fluctuation is very steady at this time. Calculation of the real value of Apollo Medical Holdings is based on 3 months time horizon. Increasing Apollo Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Apollo stock is determined by what a typical buyer is willing to pay for full or partial control of Apollo Medical Holdings. Since Apollo Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Apollo Stock. However, Apollo Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 28.6 | Real 26.88 | Hype 28.6 | Naive 28.74 |
The real value of Apollo Stock, also known as its intrinsic value, is the underlying worth of Apollo Medical Holdings Company, which is reflected in its stock price. It is based on Apollo Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Apollo Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Apollo Medical Holdings helps investors to forecast how Apollo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Apollo Medical more accurately as focusing exclusively on Apollo Medical's fundamentals will not take into account other important factors: Apollo Medical Holdings Company Current Valuation Analysis
Apollo Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Apollo Medical Current Valuation | 1.28 B |
Most of Apollo Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Apollo Medical Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Apollo Medical Holdings has a Current Valuation of 1.28 B. This is much higher than that of the sector and significantly higher than that of the Current Valuation industry. The current valuation for all Germany stocks is notably lower than that of the firm.
Apollo Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Apollo Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Apollo Medical could also be used in its relative valuation, which is a method of valuing Apollo Medical by comparing valuation metrics of similar companies.Apollo Medical is currently under evaluation in current valuation category among its peers.
Apollo Fundamentals
| Current Valuation | 1.28 B | |||
| Price To Book | 2.60 X | |||
| Price To Sales | 1.29 X | |||
| Revenue | 1.14 B | |||
| EBITDA | 112.08 M | |||
| Net Income | 49.05 M | |||
| Total Debt | 203.39 M | |||
| Cash Flow From Operations | 70.33 M | |||
| Number Of Employees | 15 | |||
| Market Capitalization | 197.6 M | |||
| Total Asset | 963.9 M | |||
| Z Score | 1.0 | |||
| Net Asset | 963.9 M |
About Apollo Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Apollo Medical Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apollo Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apollo Medical Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Apollo Stock
Apollo Medical financial ratios help investors to determine whether Apollo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Apollo with respect to the benefits of owning Apollo Medical security.